Success Metrics

Clinical Success Rate
90.0%

Based on 45 completed trials

Completion Rate
90%(45/50)
Active Trials
5(7%)
Results Posted
60%(27 trials)
Terminated
5(7%)

Phase Distribution

Ph early_phase_1
4
6%
Ph phase_3
7
10%
Ph phase_4
14
21%
Ph not_applicable
21
31%
Ph phase_2
19
28%
Ph phase_1
3
4%

Phase Distribution

7

Early Stage

19

Mid Stage

21

Late Stage

Phase Distribution68 total trials
Early Phase 1First-in-human
4(5.9%)
Phase 1Safety & dosage
3(4.4%)
Phase 2Efficacy & side effects
19(27.9%)
Phase 3Large-scale testing
7(10.3%)
Phase 4Post-market surveillance
14(20.6%)
N/ANon-phased studies
21(30.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.9%

45 of 53 finished

Non-Completion Rate

15.1%

8 ended early

Currently Active

5

trials recruiting

Total Trials

68

all time

Status Distribution
Active(6)
Completed(45)
Terminated(8)
Other(9)

Detailed Status

Completed45
unknown8
Recruiting5
Terminated5
Withdrawn3
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
68
Active
5
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (5.9%)
Phase 13 (4.4%)
Phase 219 (27.9%)
Phase 37 (10.3%)
Phase 414 (20.6%)
N/A21 (30.9%)

Trials by Status

unknown812%
withdrawn34%
recruiting57%
completed4566%
terminated57%
suspended11%
not_yet_recruiting11%

Recent Activity

Clinical Trials (68)

Showing 20 of 68 trialsScroll for more
NCT04620382Early Phase 1

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

Completed
NCT02429557Phase 1

Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

Completed
NCT05940324Phase 2

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Recruiting
NCT03844412Phase 2

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

Completed
NCT04872660Phase 4

Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET

Recruiting
NCT07306078Phase 2

Methylphenidate and Response to Alcohol Cues

Not Yet Recruiting
NCT01351805Not Applicable

Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain

Completed
NCT04444440Phase 4

Antibiotic Prophylaxis for Bladder Botox

Recruiting
NCT04782830Not Applicable

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

Recruiting
NCT06269146Phase 2

Pramipexole to Enhance Social Connections

Recruiting
NCT03018366Phase 2

Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women

Completed
NCT06097871Not Applicable

RCT of an Oral Acne Supplement for Adult Women

Completed
NCT01511614Not Applicable

Nicotine Withdrawal Symptoms and Smoking Relapse

Completed
NCT04384562Not Applicable

Studying the Role of Brain Molecules for Decision Making

Completed
NCT02248701Phase 2

Testosterone Plus Finasteride Treatment After Spinal Cord Injury

Terminated
NCT02799641Not Applicable

Effect of Multimodal Analgesia on Pain With Insertion of Levonorgestrel-releasing IUD

Completed
NCT04357951Early Phase 1

D-cycloserine Augmented Treatment for Youth With Tic Disorders

Withdrawn
NCT03176784Phase 4

UW Quitting Using Intensive Treatment Study (QUITS)

Completed
NCT03316859Phase 2

Naloxegol and Opioid-induced Constipation

Unknown
NCT03618225Phase 4

Duloxetine Role in Reducing Opioid Consumption After Thoracotomy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
68